Hybrid Quantum-Classical Algorithms for Biomarker Discovery in Multimodal Cancer Data
ORAL
Abstract
We present a hybrid quantum-classical data processing pipeline for a clinically meaningful task: biomarker discovery for precision oncology. By formulating feature selection as a higher-order polynomial constrained binary optimization (PCBO) problem, our approach captures first-, second-, and third-order biomarker interactions often ignored by traditional methods. To address constraints on quantum computational resources, we apply parameter transfer techniques to the Recursive Quantum Approximate Optimization Algorithm (RQAOA), effectively eliminating costly variational loops and reducing quantum evaluations by orders of magnitude. Through co-design of data encoding, Hamiltonian sparsification, and topology-aware compilation, the method aligns algorithmic needs with real device constraints. We benchmark the performance of classical solvers against the hybrid approach, demonstrating the potential for quantum computers to boost classical solver performance by effectively reducing problem size. We also compare our proposed PCBO approach to feature selection against classical baselines on the basis of yielding smaller, interpretable, and higher-quality feature sets. Focusing on cancer classification and treatment-response prediction, we perform resource estimations to determine when and how quantum hardware platforms may function as effective accelerators for biomedical discovery.
*This work is supported in part by Wellcome Leap as part of the 'Quantum Biomarker Algorithms for Multimodal Cancer Data' research project within the Quantum for Bio (Q4Bio) Program, and in part by the IBM-UChicago Quantum Collaboration, under agreement number MAS000364, with access to the fleet of IBM Quantum computers. This research used resources of the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 using NERSC award NERSC DDR-ERCAP0032212 and DDR-ERCAP0030280.
–
Publication:Shah, Dhirpal, Mariesa Teo, Ryan A. Robinett, Sophia Madejski, Zachary Morrell, Siddhi Ramesh, Colin Campbell et al. "Toward Quantum-Enabled Biomarker Discovery: An Outlook from Q4Bio." arXiv preprint arXiv:2509.25904 (2025).